Women’s imaging encompasses many radiology procedures related to women and the diseases that are most prevalent to women such as breast cancer or gynecological issues. Mammogram, breast ultrasound, breast MRI and breast biopsy are the most commonly used procedures.
The findings come from Sweden's Mammography Screening with Artificial Intelligence, or MASAI, a randomized clinical trial incorporating over 105,000 women.
There is limited research comparing HHUS and ABUS in second-look settings despite the fact that these exams are routinely utilized as supplemental imaging tools.
Authors of a new paper contend their findings could be beneficial in adapting public messaging related to supplemental imaging to better inform those who may need it.
Ultrasound-guided diffuse optical tomography (US-DOT) is a technique that combines the use of ultrasound with near-infrared light to create 3D pictures of tissues.
Prior research has shown that not only is contrast-enhanced spectral mammography comparable to CE-MRI in accuracy of loco-regional staging, but some studies have even found it to perform better.
The modality outperformed digital breast tomosynthesis, handheld ultrasound and automated breast ultrasound for cancer detection in a large cohort of women with dense breast tissue.
The degree of background parenchymal enhancement on CEM during certain days of a premenopausal woman's cycle could impact how radiologists interpret the exam.
In general, any COVID diagnosis raises risks of fetal harm during pregnancy, but fetuses of women who have been diagnosed with a pre-Omicron variant of the virus are most at risk of developmental impairment, according to new research.